Sleep apnea is sleep disorders that arise due to pauses in breathing or occurrence of low breathing during sleep. Each pause in breathing, called apnea, can last for several seconds to several minutes. This pause in breathing increases the concentration of carbon dioxide in blood. Often, sleep apnea cases are undiagnosed due to lack of awareness regarding the symptoms and effects. Untreated sleep apnea results in deterioration of numerous health conditions like hypertension, stroke, diabetes, heart diseases and others.
Request Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=50414
Rapidly advancing medical devices industry is one of the important factors bolstering the growth of the sleep apnea diagnostic and therapeutic devices market. The increasing pervasiveness of sleep apnea in comorbidities is expected to be imperative for this industry. The prominent circumstances that might occur owing to this disorder include type II diabetes, obesity, coronary artery disease, congestive heart failure, stroke, hypertension, and atrial fibrillation. The initiation of technologically advanced products is projected to exhibit lucrative growth in this industry.
This study analyzes estimates and forecasts the global sleep apnea diagnostic and therapeutic devices market in terms of demand based on revenue (USD Million) from 2014 to 2020. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period.
Purchase a direct copy of report with TOC @ http://www.syndicatemarketresearch.com/market-analysis/sleep-apnea-diagnostic-and-therapeutic-devices-market.html#table-of-content
The report provides a detailed view of the sleep apnea diagnostic and therapeutic devices market based on diagnostic devices and therapeutic devices. It bifurcates the diagnostic devices segment into actigraphy systems, polysomnography (PSG) device, respiratory polygraph and single-channel screening devices (pulse oximeters). Key therapeutic devices include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) device, oral appliances, oxygen devices and others. Regional segmentation includes the current and forecast demand of Sleep Apnea Diagnostic and Therapeutic Devices in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA) with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for sleep apnea diagnostics and therapeutic devices based on individual devices in all the regions and countries.
The report includes an overview of the market share of key companies in the global sleep apnea diagnostic and therapeutic devices market. Key players profiled in sleep apnea diagnostic and therapeutic devices include Phillips Healthcare, BMC Medical Co. Ltd., Braebon Medical Corporation, Cadwell Laboratories, Carefusion Corp., Compumedics Limited, Curative Medical Inc., Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical Inc., Invacare Corporation, Nihon Kohden, and ResMed.
The global sleep apnea devices market is segmented as follows:
Sleep Apnea Diagnostic and Therapeutic Devices Market: Diagnostic Devices Segment Analysis
- Actigraphy Systems
- Polysomnography (PSG) Device
- Respiratory polygraph
- Single-Channel Screening Devices (pulse Oximeters)
Sleep Apnea Diagnostic and Therapeutic Devices Market: Therapeutic Devices Segment Analysis
- Airway Clearance Systems
- Adaptive Servo-Ventilation (ASV)
- Positive Airway Pressure (PAP) Device
- Oral Appliances
- Oxygen Devices
Sleep Apnea Diagnostic and Therapeutic Devices Market: Region Segment Analysis
- North America
- Latin America
- Middle East & Africa